Company intelligence / Profile preview

Bonraybio

Taichung City, Taichung City, Taiwanbonraybio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bonraybio has commercialized a suite of AI-driven medical devices for male infertility diagnostics, including fully automated semen analyzers and sperm DNA fragmentation testing kits. Their products have received regulatory approvals in multiple regions and have won several national innovation awards. The company’s technology is recognized for its integration of advanced optics, software/hardware platforms, and proprietary algorithms to deliver rapid, standardized results[2][6].

Therapeutic areas: Men's Health
Modalities: DeviceDiagnostic instrumentAI-based analysis system
Industry: Digital Health Medical Devices

Partnerships

Not specifically disclosed in public sources as of June 2025.

Beyond the preview

Go deeper on Bonraybio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bonraybio.

Explore the full profile